News | September 07, 2024
Aster CMI Hospital and Coal India provide bone marrow transplants
Coal India has committed to providing upto Rs. 3 crore to treat thalassaemia and aplastic anaemia patients for a period of 3 years
Coal India has committed to providing upto Rs. 3 crore to treat thalassaemia and aplastic anaemia patients for a period of 3 years
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug
Critical resources will help Genvor to grow and scale biological crop protection products and innovative trait technologies
The tele-icu services which had a soft launch four months ago have already provided valuable assistance to 250+ patients in some of the remotest villages in India
Patni brings over 25 years of distinguished experience in the pharmaceutical industry
This accelerates the clinical-to-commercial process timeline and enables customers to develop the right molecule
The initiative aimed to reach and support individuals suffering from epilepsy through early detection and effective disease management
Strides’ approval for this product marks the 1st Indian approval from the USFDA for this complex formulation
Cresset’s new India site will support the growing demands of Cresset’s APAC customer base
Executes the first project for developing and manufacturing a novel anticancer mAb
Subscribe To Our Newsletter & Stay Updated
